Donehower et al., performed a comprehensive assessment of the P53 pathway involvement in 32 cancers reported by The Cancer Genome Atlas (TCGA) and found that in cancers with TP53 mutations, there was a loss of the second allele due to mutation, chromosomal deletion, or copy-neutral loss of heterozygosity in 91% of the cases14. Here, TP53 is linked to cancer.